申请人:Takeda Chemical Industries, Ltd.
公开号:US04596816A1
公开(公告)日:1986-06-24
Novel oxazole derivatives of the formula ##STR1## (wherein R.sup.1 is hydrogen or a straight, branched or cyclic alkyl group of 1 to 6 carbon atoms, R.sup.2 is hydrogen, halogen, trifluoromethyl, or a straight, branched or cyclic alkylthio of 1 to 3 carbon atoms, and n is 1 or 2) or pharmaceutically acceptable salts or esters thereof are synthesized through several routes. The derivatives have hypoglycemic, glucose tolerance improving and insulin sensitivity increasing activities and are of value as antidiabetic drugs.
新型噁唑衍生物的化学式为##STR1##(其中R.sup.1为氢或1至6个碳原子的直链、支链或环烷基,R.sup.2为氢、卤素、三氟甲基或1至3个碳原子的直链、支链或环烷硫基,n为1或2),或其药学上可接受的盐或酯可通过几种途径合成。这些衍生物具有降糖、改善葡萄糖耐量和增加胰岛素敏感性的活性,并可作为抗糖尿病药物具有价值。